T2 Biosystems Announces Plans to Consolidate and Expand Facilities in Massachusetts

LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today plans to consolidate its existing facilities and expand into a newly leased facility in Billerica, Massachusetts. The Company will consolidate its existing operations in Lexington, MA and Wilmington, MA into a 70,000 sq.ft. facility in Billerica, MA to accommodate current and future growth. The move is expected to occur during the second half of 2022.

Click here to view original post